| Page 1645 | Kisaco Research
 

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine
 

Emma La Rocque

CEO
Intimate Wellness Institute

Emma La Rocque

CEO
Intimate Wellness Institute

Emma La Rocque

CEO
Intimate Wellness Institute
 

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group
 

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Dr. Nathan Guerette serves as Director and CEO of The Female Pelvic Medicine Institute of Virginia. He is a board certified Urogynecologist specializing in minimally invasive surgical options for pelvic reconstruction and cosmetic surgery including advanced vaginal and robotic surgery as well as non-surgical options. He also holds an appointment as Associate Clinical Professor at the Medical College of Virginia, Virginia Commonwealth University in the division of Urogynecology and serves as Director of Robotic Surgery at Johnston Willis Medical Center.

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Nathan Guerette

Director & CEO and Director of Robotic Surgery
Female Pelvic Medicine Institute of Virginia and Johnston Willis Hospital

Dr. Nathan Guerette serves as Director and CEO of The Female Pelvic Medicine Institute of Virginia. He is a board certified Urogynecologist specializing in minimally invasive surgical options for pelvic reconstruction and cosmetic surgery including advanced vaginal and robotic surgery as well as non-surgical options. He also holds an appointment as Associate Clinical Professor at the Medical College of Virginia, Virginia Commonwealth University in the division of Urogynecology and serves as Director of Robotic Surgery at Johnston Willis Medical Center.

Prior to moving to Virginia, Dr. Guerette served as Director of Urogynecology at Pennsylvania Hospital, University of Pennsylvania in Philadelphia. Dr. Guerette is board certified in Female Pelvic Medicine and Reconstructive Surgery, Obstetrics and Gynecology as well as Family Medicine. He completed his Fellowship in Female Pelvic Medicine and Reconstructive Pelvic Surgery at the Cleveland Clinic Foundation in 2005 and is the first fellowship trained, board certified Urogynecologist in Central Virginia.

 

 

Sean Turner

CEO
Les Mills US

Sean Turner

CEO
Les Mills US

Sean Turner

CEO
Les Mills US
 
The Acceleration of Telehealth
9 Jul 2020
VIRTUAL WEBINAR & 1-2-1 NETWORKING | PST Timezone
As the world fights Covid-19 and life adjusts to a new normal, we are seeing a number of innovations within the women’s health eco-system. Traditional healthcare companies are looking to telehealth to bridge the gap between avoiding non-necessary contact with healthcare professionals whilst maintaining an excellent standard of care for patients in need. Healthcare providers are, at speed interrogating the pros of telehealth in women’s health, its reliability and the rate of adoption by patients.  Can telehealth be a possible solution for covid-age?Join us for a FREE webinar with experts in the Women's Health Indsutry who discuss ways you can integrate telehealth in your strategy and the challenges you must tackle head on to maintain a high level of care for your patients and consumers. Then, equip yourself with the practical application of telehealth in your business, by joining our post-webinar networking session. We know that getting hold of providers, support networks and potential business partners is becoming increasingly difficult, so we have designed a platform for you to pre-book to up to 12 meetings, 20 minutes a piece, to start conversations that you can nurture post event in telehealth and beyond. This will be your opportunity to meet with companies operating in the telehealth space and understand how they have implemented telehealth as a service specifically in the women’s health ecosystem. Delve deeper into how companies have made sideways moves to incorporate a digital offering without compromising on patients’ privacy, security and maintained their trust. There will also be opportunities for you to discuss other innovations in Women's Health, and how you can invest, grow and market your products. To make the difference and to move your business forward, join us!
 

Suhail Ishaq

President
BioCell Technology

Suhail Ishaq is a nutraceutical executive with over 25 years of industry experience. His in-depth knowledge of product development, food and drug law compliance, quality assurance, and clinical research have made him one of the most sought‐after professionals in the dietary supplement industry.

Suhail Ishaq

President
BioCell Technology

Suhail Ishaq

President
BioCell Technology

Suhail Ishaq is a nutraceutical executive with over 25 years of industry experience. His in-depth knowledge of product development, food and drug law compliance, quality assurance, and clinical research have made him one of the most sought‐after professionals in the dietary supplement industry.

 

Dr. Mark Smith

Director General
The International Natural and Organic Cosmetics Association (NATRUE)

Dr. Mark Smith graduated with a M.Chem (Hons.) degree in chemistry and an interdisciplinary PhD. between chemistry and genetics. Before joining NATRUE in June 2014, he worked in research in biotechnology (Leeds, UK) and pharmaceuticals (Montréal, Canada) where he was involved in the coordination of strategic and internationally collaborative interdisciplinary projects. Mark became Director General of NATRUE in July 2016, where he is responsible for the running of the association, and takes the lead role in all political, regulatory and scientific affairs.

 

Dr. Mark Smith

Director General
The International Natural and Organic Cosmetics Association (NATRUE)

Dr. Mark Smith

Director General
The International Natural and Organic Cosmetics Association (NATRUE)

Dr. Mark Smith graduated with a M.Chem (Hons.) degree in chemistry and an interdisciplinary PhD. between chemistry and genetics. Before joining NATRUE in June 2014, he worked in research in biotechnology (Leeds, UK) and pharmaceuticals (Montréal, Canada) where he was involved in the coordination of strategic and internationally collaborative interdisciplinary projects. Mark became Director General of NATRUE in July 2016, where he is responsible for the running of the association, and takes the lead role in all political, regulatory and scientific affairs.